
The Medicare telehealth expansion will continue at least until Dec. 31, 2022.
Keith A. Reynolds is the editor of Physicians Practice.

The Medicare telehealth expansion will continue at least until Dec. 31, 2022.

The association claims that the new surprise billing law’s arbitration provision overly favors insurers.

The agency moved quickly to approve the smaller shots.

Rising expenses continue squeezing physicians and hospitals as they try to rebound from the latest COVID-19 surge.

The vaccine is just awaiting a recommendation from the CDC before they can be rolled out.

Most respondents look online when finding a physician or other care entity.

The agreement is aimed at increasing access to the pill in low- and middle-income countries.

Nearly all respondents reported regulatory burden has increased over the past 12 months.

A previous analysis found the vaccine was 90.7 percent effective against severe COVID-19.

The assumption has been that the COVID-19 pandemic has been at the root of recent upticks in physician burnout.

Gain business tips for physicians on your schedule.

Patients are looking for user-friendly technology.

The FDA is expected to act on an EUA application for the smaller doses next week.

An analysis found that counties with more primary care had better COVID-19 related outcomes.

The administration sees pediatricians and primary care physicians taking the lead in the push.

A treasure trove of physician business tips are available online.

UnitedHealthcare’s newly launched virtual first plan is one part of a push by the industry.

The agency is expected to decide on that as well as Moderna and Johnson and Johnson boosters this week.

Nearly all respondents to a Kaufman Hall survey have experienced challenges in supply procurement.

The research suggests the less time a physician spends on an EHR the more likely they are to leave their employer.

The advisory panel is also scheduled to discuss Merck antiviral pill late next month.

The investment will boost the number of VillageMD locations to 600 by 2025 and to 1,000 by 2027.

A recommendation is expected on whether the shot should be authorized.

Indexes for prescription drugs and hospital services saw slight rises, but they were offset by a dip in physician services.

After promising result in clinical trials, the company has submitted data to regulatory bodies across the globe.

Despite the difficulty of the COVID-19 pandemic, primary care has remained resilient and used telehealth to bridge the gap.

The Biden administration says that vaccination mandates are not leading to the mass resignations in health that some expected.

There wasn’t much change in healthcare hiring in September.

Tomorrow is the last chance to see these sessions live.

The drug has proven effective in patients between 5 and 11 years old, according to Pfizer.